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INTRODUCTION
Neutrophil gelatinase-associated lipocalin (NGAL) is a member of the lipocalin protein family that has diverse functions but similar structure. The functions of NGAL are not clear, but it appears to be expressed in stress conditions and in tissues undergoing involution. NGAL is a 25-kDa secretory glycoprotein that was originally identified in human neutrophils and so was originally known as an innate immunity antibacterial factor released by activated neutrophils. NGAL is one of the most upregulated genes in the kidney soon after ischemic injury and NGAL protein was markedly induced in kidney tubule cells, and easily detected in the plasma and urine in animal models of ischemic and nephrotoxic acute kidney injury (AKI). The expression of NGAL protein was also dramatically increased in kidney tubules of humans with ischemic, septic, and posttransplant AKI
(1-6) . Cystatin C (CysC) is a 122-amino acid, 13-kDa protein that is a member of the family of cysteine proteinase inhibitors. It is the product of a "housekeeping" gene expressed in all nucleated cells and is produced at a constant rate. Because of its small size, CysC is freely filtered by the glomerulus. It is not secreted, but is reabsorbed by tubular epithelial cells and subsequently catabolized so that it does not return to the blood flow. This latter property negates calculation of a CysC clearance using urine concentrations of CysC. The use of serum CysC to estimate glomerular filtration rate is based on the same logic as the use of blood urea nitrogen and creatinine, but because it does not return to the bloodstream and is not secreted by renal tubules, it has been suggested to be closer to the "ideal" endogenous marker (7-9) . In two large cohort studies of intensive care patients that used the Risk-Injury-Failure-Loss-End Stage (RIFLE) criteria, AKI had a prevalence of approximately 36% and was significantly associated with increased mortality (10,11) . Similar results have been observed in the hospitalized population as a whole (12) , patients undergoing cardiac surgery (13) , and burn patients (14) . Recently, Wohlauer et al. (15) documented that early AKI is a harbinger of adverse outcome postinjury, outperforming hepatic, cardiac, or pulmonary dysfunction as a predictor of multiple organ failure and death, and so prevention of early AKI and a better understanding of organ crosstalk may help to reduce AKIassociated morbidity, mortality, and obligatory costs of that complication. Thus, the current study (screening study) was designed as a trial for determination of the frequency of AKI among patients admitted to surgical ICU for variant indications and to determine the predictability of at admission AKI biomarkers levels for the possibility of AKI development. Patients who were free of AKI at 48-hr after ICU admission had nonsignificantly (p>0.05) higher at admission sCr compared to control subjects. On contrary, patients developed AKI had significantly (p<0.05) higher at admission sCr compared to controls and to AKI-free patients. Patients developed AKI stage-1 had significantly (p<0.05) higher at admission sCr levels compared to controls, but had nonsignificantly (p>0.05) higher levels compared to AKI-free patients. Patients developed AKI stage-2 had significantly (p<0.05) higher at admission sCr levels compared to controls, AKI-free patients and to patients had AKI stage-1. Mean patients' sCr estimated at 48-hr after ICU admission was significantly (p<0.05) higher compared to their respective at admission sCr level. Moreover, mean sCr estimated at 48-hr after ICU was significantly (p<0.05) higher in patients compared to controls with significantly (p<0.05) higher sCr estimated at 48-hr in patients developed AKI compared to controls and to AKI-free patients. Patients had AKI stage-2 showed significantly (p<0.05) higher sCr estimated at 48-hr compared to controls, AKI-free patients and patients had AKI stage-1. Patients had AKI stage-1 showed significantly (p<0.05) higher sCr estimated at 48-hr compared to controls and AKI-free patients. Patients free of AKI showed significantly (p<0.05) higher sCr estimated at 48-hr compared to controls, (Table 4 , Fig. 2 ).
PATIENTS & METHODS
At admission plasma NGAL levels were significantly (p<0.05) higher in patients compared to controls, however, AKI-free patients showed non-significantly (p>0.05) higher plasma NGAL levels compared to controls. Patients developed AKI had significantly (p<0.05) higher plasma NGAL levels compared to AKI-free patients with significantly (p<0.05) higher levels in patients developed AKI-2 compared to those developed AKI-1, (Table 5, Fig. 3) . Similarly, at admission serum CysC levels were significantly (p<0.05) higher in patients compared to controls and in patients developed AKI-2 compared both to AKI-free patients and those developed AKI-1 with non-significantly (p>0.05) higher levels detected in patients had AKI-1 compared to AKI-free patients, (Table  5 , Fig. 4 ).
Regression analysis of at admission clinical and laboratory data as predictors for development of AKI, defined plasma NGAL as the significant predictor for possibility of development of AKI in four models, followed by at admission serum cystatin C in three models, TISS-28 injury severity score in two models and at admission serum creatinine in one model, (Table 6 ). ROC curve analysis for specificity of these predictors, defined at admission plasma NGAL as the significant specific predictor for possibility of development of AKI, followed by serum cystatin C and lastly at admission TISS-28 score and presence of additional co-morbidities, (Table 7 studied 522 adults in three distinct cohorts including patients with sepsis, shock, major surgery, and trauma and reported moderate to severe AKI in 14% of studied patients. Talving et al.
(25) reported a frequency of 13.4% among 521 studied pediatrics admitted to trauma surgical ICU.
Despite the significantly higher at admission sCr in patients developed AKI in comparison to controls and AKI-free patients, patients developed AKI stage-1 (n=39; 62.9%) had their at admission sCr was in range of 0.82-1.07 mg/dl which falls in the normal range of sCr. These findings indicated the shortage of at admission estimation of sCr as a predictor for the possibility of development of AKI. In support of that assumption, regression analysis failed to define at admission sCr as significant specific predictor except in one of four models of analysis. In hand with these data, de Geus et al. (26) documented that efforts to change the clinical course of AKI have failed because clinically available therapeutic measures are currently lacking, and early detection is impossible with serum creatinine.
At admission high serum cystatin C (CysC) levels were found as a significant specific predictor for AKI in three models of regression analysis with high AUC; however its predictivity was inferior to that of NGAL and when coupled its predictivity became better. In support of these findings, Cai et al. (27) reported that CysC is a more accurate and sensitive marker for identification of acute impaired renal function in major burn patients than sCr, so it is important to measure CysC and calculate estimated glomerular filtration rate to prevent acute renal failure and modify drug doses in burn patients, especially those of older age and with major burn areas. Aydoğdu et al.
(28) found plasma and urinary CysC and urinary NGAL are useful markers in predicting AKI in septic ICU patients.
At admission plasma NGAL levels were found to be the best early predictor for the possibility of AKI development in patients admitted to surgical ICU. This outcome was confirmed statistically, where both ROC and regression analyses defined it as the significant specific predictor for the possibility of development of AKI. In line of these data, Mårtensson et al. (29) found plasma NGAL is raised in patients with systemic immune response, severe sepsis, and septic shock. Bagshow et al. (30) reported that septic AKI patients have higher detectable plasma NGAL compared with non-septic AKI patients and these differences in NGAL values in septic AKI have diagnostic and clinical relevance as well as pathogenetic implications.
Constantin et al.
(31) assessed the ability of plasma NGAL to predict AKI in adult ICU patients and found its sensitivity was 85% and specificity was 97% for predication of AKI. Koyner et al.
(32) tried to evaluate whether kidney injury biomarkers measured at the time of first clinical diagnosis of early AKI after cardiac surgery can forecast AKI severity and found that each biomarker improved risk classification compared with the clinical model alone, with plasma NGAL performing the best. Mellor & Woods (33) found serum NGAL levels raised in both groups of casualties, blast and gunshot wounds, and was significantly predictive of death or renal failure at ICU admission, 12 and 24 hours after injury.
Additionally, presence of additional co-morbidities and high TISS-28 scores were found to be specific predictors for AKI, however, AUC for both clinical data was less than AUC for NGAL, thus combined clinical judgment and high at admission plasma NGAL improved the predictivity for the possibility of development of AKI. In line with these data; Di Somma et al. (34) reported that the AUC, obtained at time-0 (T0), for blood NGAL alone in the AKI group was 0.80 and when NGAL at T0 was added to the physician's initial clinical judgment the AUC was increased to 0.90, significantly greater when compared to the AUC of the T0 estimated glomerular filtration rate and concluded that assessment of a patient's initial blood NGAL when admitted to hospital improved the initial clinical diagnosis of AKI and predicted in-hospital mortality.
In support of the predictivity of estimation of plasma NGAL, Kümpers et al. (35) reported that serum NGAL can be used as an outcomespecific biomarker in critically ill patients at initiation of renal replacement therapy and results indicated that serum NGAL could be used as an independent predictor of 28-day mortality in ICU patients with dialysis-dependent AKI. Recently, Polat et al. (36) reported that in a heterogeneous group of critically ill children with established AKI, NGAL in both urine and serum at the time of patient presentation discriminated intrinsic AKI from prerenal AKI.
The obtained results and review of literature allowed concluding that patients admitted to surgical ICU had a risk of 36.9% for AKI development and combined high TISS-28 severity score and high at admission plasma NGAL levels could early predict the possibility of AKI development with significantly high specificity. 
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